US Patent Issued to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION, GANGNEUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY COOPERATION GROUP on Dec. 30 for "Pharmaceutical composition comprising 4-hexylresorcinol as active ingredient for prevention or treatment of bone disease" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,237, issued on Dec. 30, was assigned to KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Daegu, South Korea) and GANGNEUNG-WONJU NATIONAL UNIVERSITY INDUSTRY ACADEMY COOPERATION GROUP (Gangneung-si, South Korea).

"Pharmaceutical composition comprising 4-hexylresorcinol as active ingredient for prevention or treatment of bone disease" was invented by Je-Yong Choi (Daegu, South Korea), Xiangguo Che (Daegu, South Korea), Hyun-Ju Kim (Daegu, South Korea), Dong-Kyo Lee (Changwon-si, South Korea), Seong-Gon Kim (Seoul, South Korea) and Xian Jin (Daegu, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention ...